New Results Help Predict Treatment Response In Colorectal Cancer
Wednesday, September 17, 2008 - 20:35
in Health & Medicine
Gene marker indicates doubling of survival time in advanced colorectal cancer treated with cetuximab. A study shows value of circulating tumor cells in patients on targeted therapy.